Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Skoler-Karpoff, Stephanie, Ramjee, Gita, Ahmed, Khatija, Altini, Lydia, Plagianos, Marlena Gehret, Friedland, Barbara, Govender, Sumen, De Kock, Alana, Cassim, Nazira, Palanee, Thesla, Dozier, Gregory, Maguire, Robin, Lahteenmaki, Pekka · 2008 · The Lancet

Abstract

Background Female-initiated HIV-prevention options, such as microbicides, are urgently needed. We assessed Carraguard, a carrageenan-based compound developed by the Population Council, for its efficacy and long-term safety in prevention of HIV infection in women. Methods We undertook a randomised, placebo-controlled, double-blind trial in three South African sites in sexually-active, HIV-negative women, aged 16 years and older. 6202 participants, who were randomly assigned by a block randomisation scheme to Carraguard (n=3103) or placebo (methylcellulose [n=3099]), were instructed to use one applicator of gel plus a condom during each vaginal sex act. Participants were followed up for up to 2 years. Visits every 3 months included testing for HIV presence and pregnancy, pelvic examinations, risk reduction counselling, and treatment for curable sexually transmitted infections and symptomatic vaginal infections. The primary outcome was time to HIV seroconversion. Analysis was in the efficacy population (a subset of the intention-to-treat population, excluding participants for whom efficacy could not be assessed). This study is registered with ClinicalTrials.gov, number NCT00213083. Findings For the primary outcome (time to HIV seroconversion) we analysed 3011 women in the Carraguard group and 2994 in the placebo group. HIV incidence was 3.3 per 100 woman-years (95% CI 2.8-3.9) in the Carraguard group (134 events) and 3.8 per 100 woman-years (95% CI 3.2-4.4) in the placebo group…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(08)61842-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. Phillips DM, Tan X, Pearce-Pratt R, Zacharopoulos V. Towards developing a vaginal formulation which will prevent infection by human immunodeficiency virus. In: Gillet J-Y, Bongain A, eds. Proceedings from the 2nd International Symposium on AIDS and Reproduction. Montpellier, France; May 6–8, 1993.
  2. Coetzee N, Hoosen A, Blanchard K, et al. Safety of a lambda carrageenan microbicide (Carraguard) in South Africa. Proceedings of the 2002 Microbicides Conference. Antwerp, Belgium; May 12–15, 2002.

Cited by

See all 507

Metadata

Authors
Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., Govender, S., De Kock, A., Cassim, N., Palanee, T., Dozier, G., Maguire, R., & Lahteenmaki, P.
Affiliations
  • Population Council (US)
  • Sefako Makgatho Health Sciences University (ZA)
  • University of Cape Town (ZA)
Corresponding author
Friedland, Barbara
Venue
The Lancet
Publisher
Elsevier BV
Published
2008-12
Volume
372
Issue
9654
Pages
1977-1987
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2144198686
Cited by
502
References
41
Citations by year
2026: 2 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 19 · 2020: 14 · 2019: 18 · 2018: 18 · 2017: 10 · 2016: 18 · 2015: 29 · 2014: 51 · 2013: 50 · 2012: 74
FWCI
35.57
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
HIV prevention, microbicides, vaginal gel, HIV seroconversion, HIV incidence, women, condom use, vaginal candidiasis, vaginal candidiasis treatment, long-term safety, South Africa, HIV prevention in women, sexually transmitted infections
MeSH terms
Adolescent, Adult, Carrageenan, Chemistry, Pharmaceutical, Double-Blind Method, Female, Humans, Sexual Behavior, South Africa, Vaginal Creams, Foams, and Jellies, HIV Infections, Incidence, Women's Health, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)61842-5
The paper
Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., Govender, S., De Kock, A., Cassim, N., Palanee, T., Dozier, G., Maguire, R., & Lahteenmaki, P. (2008). Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)61842-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.